Full-Time
Confirmed live in the last 24 hours
Computational platform for drug discovery research
Junior, Mid
United Kingdom
Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and development across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict how different compounds will interact, which can significantly speed up the research process. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative drug discovery programs, allowing them to work closely with clients on specific projects. The company's goal is to enhance scientific research and innovation by providing powerful tools and resources that support the development of new therapies.
Company Stage
IPO
Total Funding
$362.7M
Headquarters
New York City, New York
Founded
1990
Help us improve and share your feedback! Did you find this helpful?